BioCentury | Aug 27, 2015
Distillery Techniques

Techniques: A mouse model of severe asthma with high interferon (IFN) γ levels

...sensitivity to corticosteroid therapy of severe asthma patients. In the model, vector-mediated expression of secretory leukocyte protease inhibitor (SLPI...
BioCentury | Apr 9, 2001
Company News

Arriva, Genzyme Transgenics, Aventis S.A, Baxter Healthcare Corp., Bayer autoimmune/inflammation, dermatology news

...the use of alpha 1-antitrypsin ( AAT ) and other protease inhibitors such as secretory leukocyte protease inhibitor (SLPI...
BioCentury | Apr 27, 1998
Strategy

Amgen cuts Boulder loose

...antagonist ), both of which are in Phase I studies to treat rheumatoid arthritis. Secretory leukocyte protease inhibitor (SLPI...
...Thousand Oaks, so the decision may not limit AMGN's inflammation program to STNFr-1, IL-1ra and SLPI...
BioCentury | Apr 27, 1998
Strategy

Amgen cuts Boulder loose

...antagonist ), both of which are in Phase I studies to treat rheumatoid arthritis. Secretory leukocyte protease inhibitor (SLPI...
...Thousand Oaks, so the decision may not limit AMGN's inflammation program to STNFr-1, IL-1ra and SLPI...
BioCentury | Sep 8, 1997
Strategy

Amgen finds no synergy with Synergen

...deal. They include interleukin-1 receptor antagonist (IL-1ra), tumor necrosis factor binding protein (TNF-bp), and secretory leukocyte protease inhibitor (SLPI...
...receptor-1) is expected to begin Phase I/II testing in the first half of 1998, and SLPI...
BioCentury | Oct 21, 1996
Company News

Amgen deal

...said it will seek a partner for recombinant Serine Protease Inhibitor (SPI, also known as SLPI...
BioCentury | May 3, 1993
Strategy

Product race, patent risk

...priority. Although Antril is still SYGN's top project, other products in its pipeline, such as SLPI...
BioCentury | Apr 12, 1993
Strategy

What SYGN did

...asthma, inflammatory bowel disease, psoriasis and ocular inflammation. A small on-going Phase II trial of SLPI...
...asthma, inflammatory bowel disease, psoriasis and ocular inflammation. A small on-going Phase II trial of SLPI...
...asthma, inflammatory bowel disease, psoriasis and ocular inflammation. A small on-going Phase II trial of SLPI...
Items per page:
1 - 8 of 8